5. Pathological node staging (Union for International Cancer Control-American Joint Committee on Cancer [UICC/AJCC] 7th edition): patients must have had axillary lymph node dissection for evaluation of pathologic nodal status. Only patients with > 4 metastatic axillary node will be eligible (>pN2).